电休克疗法
耐受性
药物治疗
医学
重症监护医学
精神分裂症(面向对象编程)
萧条(经济学)
精神科
重性抑郁障碍
不利影响
内科学
心情
经济
宏观经济学
作者
Thomas C. Baghai,Hans-Jürgen Möller
标识
DOI:10.31887/dcns.2008.10.1/tcbaghai
摘要
In spite of recent developments in the pharmacotherapy of depressive disorders, the delay until clinical improvement can be achieved, and the considerable rate of nonresponse and nonremission, are major problems which remain unresolved. Electroconvulsive therapy (ECT) is a nonpharmacologic biological treatment which has been proven to be a highly effective treatment option, predominantly for depression, but also for schizophrenia and other indications. Though there is a lack of controlled investigations on long-term treatments, ECT can also be used for relapse prevention during maintenance therapies. The safety and tolerability of electroconvulsive treatment have been enhanced by the use of modified stimulation techniques and by progress in modern anesthesia. Thus, today a safe treatment can also be offered to patients with higher somatic risks. ECT still represents an important option, especially in the therapy of treatment-resistant psychiatric disorders after medication treatment failures. Earlier consideration of ECT may reduce the rate of chronic and difficult-to-treat psychiatric disorders.
科研通智能强力驱动
Strongly Powered by AbleSci AI